Maintenance treatment with thalidomide after autologous transplantation for myeloma:: Final analysis of a prospective randomized study of the "Intergroupe Francophone du Myelome".

被引：0
|
作者：
Attal, M [1 ]
Harousseau, JL [1 ]
Leyvraz, S [1 ]
Doyen, C [1 ]
Hulin, C [1 ]
Benboubker, L [1 ]
Agha, IY [1 ]
Bourhis, JH [1 ]
Garderet, L [1 ]
Sotto, JJ [1 ]
Michallet, M [1 ]
Renaud, M [1 ]
Voillat, L [1 ]
Berthou, C [1 ]
Marit, G [1 ]
Monconduit, M [1 ]
Dumonté, C [1 ]
Caillot, D [1 ]
Mathiot, C [1 ]
Avet-Loiseau, H [1 ]
机构：
[1] Hop Purpan, Hematol Serv, Toulouse, France
来源：
BLOOD | 2005年 / 106卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1148
引用
收藏
页码：335A / 335A
页数：1
相关论文
共 50 条
  • [31] Thalidomide plus Dexamethasone as Maintenance after Single Autologous Stem Cell Transplantation Improves Progression-Free Survival (PFS) in Advanced Multiple Myeloma. A Prospective Brazilian Randomized Trial
    Maiolino, Angelo
    Hungria, Vania T.
    Oliveira-Duarte, G.
    Oliveira, L. C.
    Mercante, D. R.
    Miranda, Ecm
    Quero, A.
    Miguel Peres, A. L.
    Barros, J. C.
    Tanaka, P.
    Magalhaes, R. P.
    Rego, Eduardo M.
    Nucci, M.
    Lorand-Metze, Irene
    Lima, C. S. P.
    Zalcberg, I.
    Braggio, E.
    De Souza, Camino
    BLOOD, 2008, 112 (11) : 1269 - 1269
  • [32] Comparison of 200 mg/m2 melphalan and 8 Gy total body irradiation plus 140 mg/m2 melphalan as conditioning regimens for peripheral blood stem cell transplantation in patients with newly diagnosed multiple myeloma:: final analysis of the Intergroupe Francophone du Myelome 9502 randomized trial
    Moreau, P
    Facon, T
    Attal, M
    Hulin, C
    Michallet, M
    Maloisel, F
    Sotto, JJ
    Guilhot, F
    Marit, G
    Doyen, C
    Jaubert, A
    Fuzibet, JG
    François, S
    Benboubker, L
    Monconduit, M
    Voillat, L
    Macro, M
    Berthou, C
    Dorvaux, V
    Pignon, B
    Rio, B
    Matthes, T
    Casassus, P
    Caillot, D
    Najman, N
    Grosbois, B
    Bataille, R
    Harousseau, JL
    BLOOD, 2002, 99 (03) : 731 - 735
  • [33] Maintenance treatment after autologous stem cell transplantation in patients with multiple myeloma - new drugs for multiple myeloma
    Maiolino, Angelo
    Garnica, Marcia
    LEUKEMIA RESEARCH, 2018, 73 : S3 - S4
  • [34] Sequential Bortezomib, Dexamethasone, and Thalidomide Maintenance Therapy after Single Autologous Peripheral Stem Cell Transplantation in Patients with Multiple Myeloma
    Sahebi, Firoozeh
    Frankel, Paul H.
    Farol, Len
    Krishnan, Amrita Y.
    Cai, Ji-lian
    Somlo, George
    Thomas, Sandra H.
    Reburiano, Eunicia
    Popplewell, Leslie L.
    Parker, Pablo M.
    Spielberger, Ricardo T.
    Karanes, Chatchada
    Htut, Myo
    Ruel, Christopher
    Duarte, Lupe
    Murata-Collins, Joyce L.
    Forman, Stephen J.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2012, 18 (03) : 486 - 492
  • [35] Thalidomide maintenance, is it still effective in extending survival after autologous stem cell transplantation in patients with newly diagnosed multiple myeloma
    Kim, D. J.
    Lee, H. S.
    Kim, Y. S.
    Jung, S. M.
    Min, C. -K.
    Lee, W. S.
    Shin, H. -J.
    Lee, J. -J.
    Kim, K.
    Yoon, D. H.
    Eom, H. -S.
    BONE MARROW TRANSPLANTATION, 2016, 51 : S19 - S20
  • [36] Autologous-allogeneic versus autologous tandem stem cell transplantation and maintenance therapy with thalidomide for multiple myeloma patients under 60 years of age: a prospective, phase II study
    Kroeger, Nicolaus
    Wulf, Gerald
    Hegenbart, Ute
    Burchert, Andreas
    Stelljes, Matthias
    Gagelmann, Nico
    Brecht, Arne
    Kaufmann, Martin
    Mueller, Lutz
    Ganser, Arnold
    Wolf, Dominik
    Bethge, Wolfgang
    Bornhaeuser, Martin
    Kiehl, Michael
    Wagner, Eva -Maria
    Schmid, Christoph
    Reinhardt, Hans Christian
    Kobbe, Guido
    Salwender, Hans
    Heinicke, Thomas
    Kropff, Martin
    Heinzelmann, Marion
    Ayuk, Francis
    Truemper, Lorenz
    Neubauer, Andreas
    Voelp, Andreas
    Kluychnikov, Evgeny
    Schoenland, Stefan
    Wolschke, Christine
    HAEMATOLOGICA, 2024, 109 (05) : 1469 - 1479
  • [37] Second autologous transplantation for multiple myeloma patients relapsing after the first autograft -: a pilot study for the evaluation of experimental maintenance therapies -: Report of the prospective non-randomized pilot study of the Czech Myeloma group
    Krivanová, A
    Hájek, R
    Krejcí, M
    Scudla, V
    Indrák, K
    Bacovsky, J
    Büchler, T
    Svobodník, A
    Adam, Z
    Mayer, J
    Vorlícek, J
    ONKOLOGIE, 2004, 27 (03): : 275 - 279
  • [38] Autologous-Allogeneic Vs Autologous Tandem Stem Cell Transplantation And Maintenance With Thalidomide For Patients With Multiple Myeloma (MM) and Age <60 Years: A Prospective Phase II-study
    Kroeger, Nicolaus
    Hegenbart, Ute
    Stelljes, Matthias
    Kaufmann, Martin
    Mueller, Lutz
    Gagelmann, Nico
    Christian, Koenecke
    Schmid, Christoph
    Kobbe, Guido
    Wagner, Eva-Maria
    Bornhaeuser, Martin
    Kiehl, Michael
    Wulf, Gerald
    Bethge, Wolfgang
    Burchert, Andreas
    Wolf, Dominik
    Heinicke, Thomas
    Heinzelmann, Marion
    Wolschke, Christine
    Voelp, Andreas
    Schoenland, Stefan
    BONE MARROW TRANSPLANTATION, 2021, 56 (SUPPL 1) : 134 - 135
  • [39] Treatment of myeloma patients relapsed after frontline autologous stem cell transplantation with the association of thalidomide, dexamethasone and zoledronate.
    Musto, P
    Bodenizza, C
    Falcone, A
    Sanpaolo, G
    Cascavilla, N
    Melillo, L
    Dell'Olio, M
    La Sala, A
    Mantuano, S
    Nobile, M
    Scalzulli, PR
    Greco, MM
    Carella, AM
    Beltrami, G
    Carella, AM
    BLOOD, 2003, 102 (11) : 382B - 382B
  • [40] Successful treatment of multiple myeloma relapsing after high-dose therapy and autologous transplantation with thalidomide as a single agent
    Zomas, A
    Anagnostopoulos, N
    Dimopoulos, MA
    BONE MARROW TRANSPLANTATION, 2000, 25 (12) : 1319 - 1320
12345